0001398659-23-000039.txt : 20231206
0001398659-23-000039.hdr.sgml : 20231206
20231206161634
ACCESSION NUMBER: 0001398659-23-000039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231204
FILED AS OF DATE: 20231206
DATE AS OF CHANGE: 20231206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stein Kathryn Vanpelt
CENTRAL INDEX KEY: 0001806002
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33626
FILM NUMBER: 231469798
MAIL ADDRESS:
STREET 1: 40 WEST 24TH STREET
STREET 2: APT 3N
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Genpact LTD
CENTRAL INDEX KEY: 0001398659
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
IRS NUMBER: 980533350
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CANON'S COURT
STREET 2: 22 VICTORIA STREET
CITY: HAMILTON
STATE: D0
ZIP: HM 12
BUSINESS PHONE: 4412952244
MAIL ADDRESS:
STREET 1: CANON'S COURT
STREET 2: 22 VICTORIA STREET
CITY: HAMILTON
STATE: D0
ZIP: HM 12
4
1
wk-form4_1701897384.xml
FORM 4
X0508
4
2023-12-04
0
0001398659
Genpact LTD
G
0001806002
Stein Kathryn Vanpelt
C/O GENPACT LLC
FIFTH AVENUE, 14TH FLOOR
NEW YORK
NY
10175
0
1
0
0
Senior Vice President
0
Common Shares
2023-12-04
4
M
0
39050
27.70
A
143111
D
Common Shares
2023-12-04
4
S
0
39050
34.8501
D
104061
D
Common Shares
2023-12-04
4
S
0
18286
34.8492
D
85775
D
Employee Stock Option (Right to Buy)
27.70
2023-12-04
4
M
0
39050
0
D
2029-01-10
Common Shares
39050
84051
D
Includes 213 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 17, 2023. The reporting person currently holds a total of 3,337 shares under the ESPP.
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $34.66 to $35.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $34.67 to $34.99. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The option vested 50% on January 10, 2022 and the remainder will vest on January 10, 2024, subject to the reporting person's continued service through such date.
/s/ Thomas D. Scholtes, as Attorney-in-fact for Kathryn Stein
2023-12-06